| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Development of HIV with drug resistance after CD4 cell count-guided structured treatment interruptions in patients treated with highly active antiretroviral therapy after dual-nucleoside analogue treatment.
|
Clin Infect Dis
|
2005
|
1.52
|
|
2
|
National expansion of antiretroviral treatment in Thailand, 2000-2007: program scale-up and patient outcomes.
|
J Acquir Immune Defic Syndr
|
2009
|
1.40
|
|
3
|
Incidence and risk factors for rash in Thai patients randomized to regimens with nevirapine, efavirenz or both drugs.
|
AIDS
|
2005
|
1.28
|
|
4
|
Pharmacokinetics and 24-week efficacy/safety of dual boosted saquinavir/lopinavir/ritonavir in nucleoside-pretreated children.
|
Pediatr Infect Dis J
|
2005
|
1.26
|
|
5
|
Association of polypectomy techniques, endoscopist volume, and facility type with colonoscopy complications.
|
Gastrointest Endosc
|
2013
|
1.07
|
|
6
|
Neurocognitive impairment and psychiatric comorbidity in well-controlled human immunodeficiency virus-infected Thais from the 2NN Cohort Study.
|
J Neurovirol
|
2010
|
1.07
|
|
7
|
Clinical case definition and manifestations of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome.
|
AIDS
|
2009
|
1.06
|
|
8
|
National program scale-up and patient outcomes in a pediatric antiretroviral treatment program, Thailand, 2000-2007.
|
J Acquir Immune Defic Syndr
|
2010
|
1.06
|
|
9
|
Immunologic markers as predictors of tuberculosis-associated immune reconstitution inflammatory syndrome in HIV and tuberculosis coinfected persons in Thailand.
|
AIDS Res Hum Retroviruses
|
2009
|
1.02
|
|
10
|
HIV risk behavior among HIV-infected men who have sex with men in Bangkok, Thailand.
|
AIDS Behav
|
2012
|
1.02
|
|
11
|
High virologic response rate after second-line boosted protease inhibitor-based antiretroviral therapy regimens in children from a resource limited setting.
|
AIDS Res Ther
|
2012
|
1.00
|
|
12
|
Delivery system characteristics and their association with quality and costs of care: implications for accountable care organizations.
|
Health Care Manage Rev
|
2015
|
1.00
|
|
13
|
Directly observed therapy and improved tuberculosis treatment outcomes in Thailand.
|
PLoS One
|
2008
|
0.99
|
|
14
|
Interindividual variability of once-daily ritonavir boosted saquinavir pharmacokinetics in Thai and UK patients.
|
J Antimicrob Chemother
|
2005
|
0.93
|
|
15
|
Development of normative neuropsychological performance in Thailand for the assessment of HIV-associated neurocognitive disorders.
|
J Clin Exp Neuropsychol
|
2012
|
0.92
|
|
16
|
Screening HIV-infected women for cervical cancer in Thailand: findings from a demonstration project.
|
Sex Transm Dis
|
2007
|
0.88
|
|
17
|
A feasibility study of immediate versus deferred antiretroviral therapy in children with HIV infection.
|
AIDS Res Ther
|
2008
|
0.85
|
|
18
|
Three-year durability of dual-nucleoside versus triple-nucleoside therapy in a Thai population with HIV infection.
|
J Acquir Immune Defic Syndr
|
2004
|
0.83
|
|
19
|
A prospective study of efficacy and safety of once-daily saquinavir/ritonavir plus two nucleoside reverse transcriptase inhibitors in treatment-naive Thai patients.
|
Antivir Ther
|
2005
|
0.83
|
|
20
|
Highly active antiretroviral therapy (HAART) retreatment in patients on CD4-guided therapy achieved similar virologic suppression compared with patients on continuous HAART: the HIV Netherlands Australia Thailand Research Collaboration 001.4 study.
|
J Acquir Immune Defic Syndr
|
2005
|
0.82
|
|
21
|
The use of pharmacokinetically guided indinavir dose reductions in the management of indinavir-associated renal toxicity.
|
J Antimicrob Chemother
|
2006
|
0.80
|
|
22
|
Polypectomy techniques, endoscopist characteristics, and serious gastrointestinal adverse events.
|
J Surg Oncol
|
2014
|
0.78
|
|
23
|
Patient Comorbidity and Serious Adverse Events after Outpatient Colonoscopy: Population-based Study From Three States, 2006 to 2009.
|
Dis Colon Rectum
|
2016
|
0.78
|
|
24
|
In vivo cell-mediated immunity in subjects with undetectable viral load on protease inhibitor-based versus non-protease inhibitor-based highly active antiretroviral therapy.
|
J Acquir Immune Defic Syndr
|
2003
|
0.77
|
|
25
|
Acute Low Back Pain: Differential Somatosensory Function and Gene Expression Compared With Healthy No-Pain Controls.
|
Clin J Pain
|
2016
|
0.77
|
|
26
|
Viral decay dynamics in HIV-infected patients receiving ritonavir-boosted saquinavir and efavirenz with or without enfuvirtide: a randomized, controlled trial (HIV-NAT 012).
|
J Infect Dis
|
2006
|
0.76
|
|
27
|
Resistance to dual nucleoside reverse-transcriptase inhibitors in children infected with HIV clade A/E.
|
Clin Infect Dis
|
2004
|
0.76
|
|
28
|
External quality assessment program on CD4+ T-lymphocyte counts for persons with HIV/AIDS in Thailand: history and accomplishments.
|
Asian Pac J Allergy Immunol
|
2009
|
0.75
|
|
29
|
Saquinavir trough concentration before and after switching NRTI to tenofovir in patients treated with once-daily saquinavir hard gel capsule/ritonavir 1600 mg/100 mg.
|
Antivir Ther
|
2004
|
0.75
|
|
30
|
No effect of interleukin-2 on IgE levels given in addition to antiretroviral therapy in HIV-infected adults with CD4 >300 cells/mm3.
|
Asian Pac J Allergy Immunol
|
2005
|
0.75
|